Summary:
A phase 2 research study to evaluate the safety and efficacy of an investigational research medicine in patients with Asthma.
Qualified Participants Must:
Be 18-60 years of age
Have a diagnosis of Asthma
Qualified Participants May Receive:
Up to $300 for time and travel my be provided to those who qualify